s-OMX Minoxidil 2.5 mg Tablets offer an effective solution for various types of hair loss, including Androgenetic Alopecia (AGA), Telogen Effluvium (TE), and Alopecia Areata (AA). With its clinically proven formula, s-OMX helps stimulate hair growth, reduce shedding, and enhance overall scalp health. Designed for both men and women, this once-daily tablet is easy to use and fits seamlessly into your routine.
s-OMX Minoxidil 2.5 mg Tablets are the next generation of hair loss treatment, providing a convenient and powerful alternative to topical solutions. Formulated with the trusted hair regrowth ingredient Minoxidil, s-OMX works by stimulating blood flow to the scalp, revitalizing hair follicles, and promoting thicker, healthier hair growth.
s-OMX is a widely studied and preferred option due to its proven effectiveness in treating male and female pattern hair loss. The scored tablet allows for flexible dosing, ensuring safe usage for different hair loss severities. Clinical studies have demonstrated significant hair regrowth and reduced shedding after consistent use, with minimal scalp irritation or texture changes.
Perfect for daily use, s-OMX tablets offer more treatment options, fewer side effects like scalp inflammation, and require lower enzymatic activity for bioactivation compared to traditional treatments.
Hair thinning, noticeable shedding, and reduced density.
Fuller, denser hair with reduced shedding and healthier scalp condition.
Most users notice improvement within 3 to 6 months of consistent use.
Yes, with recommended dosages between 0.25 mg to 1.25 mg.
Side effects are minimal but may include mild dizziness or hypertrichosis (increased hair growth in unintended areas).
Yes, it can complement other treatments like finasteride or topical minoxidil.
Yes, consult your healthcare provider for appropriate dosage and suitability.
Silamed Life Sciences introduced in India in 2017 aspiring towards Strengthening Lives by Aiming to deliver Safe and Better treatment options to Health Care Professionals and Welfare of our Patients.